Nick Sheron

12.7k total citations · 3 hit papers
103 papers, 5.6k citations indexed

About

Nick Sheron is a scholar working on Epidemiology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Nick Sheron has authored 103 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Epidemiology, 36 papers in Pathology and Forensic Medicine and 36 papers in Hepatology. Recurrent topics in Nick Sheron's work include Liver Disease Diagnosis and Treatment (38 papers), Alcohol Consumption and Health Effects (36 papers) and Liver Disease and Transplantation (26 papers). Nick Sheron is often cited by papers focused on Liver Disease Diagnosis and Treatment (38 papers), Alcohol Consumption and Health Effects (36 papers) and Liver Disease and Transplantation (26 papers). Nick Sheron collaborates with scholars based in United Kingdom, United States and Australia. Nick Sheron's co-authors include Bruce Neal, Paul Lincoln, Thaksaphon Thamarangsi, Carlos Augusto Monteiro, David Stückler, Rob Moodie, Sally Casswell, Harry Millward‐Sadler, Adrian C Bateman and Ian Gilmore and has published in prestigious journals such as The Lancet, PLoS ONE and Hepatology.

In The Last Decade

Nick Sheron

99 papers receiving 5.5k citations

Hit Papers

Profits and pandemics: prevention of harmful effects of t... 2013 2026 2017 2021 2013 2018 2017 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries
    2013 1.1k citations Rob Moodie, David Stückler et al. The Lancet profile →
  2. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
    2018 474 citations Helena Cortez‐Pinto, Francesco Negro et al. Journal of Hepatology profile →
  3. Guidelines on the management of abnormal liver blood tests
    2017 340 citations Philip N. Newsome, R Cramb et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nick Sheron United Kingdom 33 2.9k 1.5k 1.1k 822 706 103 5.6k
Witold Zatoński Poland 51 1.4k 0.5× 218 0.1× 1.1k 1.0× 1.6k 2.0× 1.0k 1.5× 258 9.1k
Susan L. Stewart United States 48 1.5k 0.5× 467 0.3× 815 0.7× 1.2k 1.4× 1.3k 1.8× 229 7.7k
David Kershenobich Mexico 33 1.8k 0.6× 1.3k 0.8× 545 0.5× 101 0.1× 251 0.4× 165 3.7k
Freddy Sitas Australia 37 1.5k 0.5× 112 0.1× 483 0.4× 662 0.8× 494 0.7× 127 6.5k
Meredith S. Shiels United States 54 2.8k 0.9× 256 0.2× 1.8k 1.6× 609 0.7× 366 0.5× 202 9.3k
Yumei Cao United States 37 1.4k 0.5× 984 0.6× 144 0.1× 412 0.5× 454 0.6× 107 5.4k
J F Mayberry United Kingdom 52 3.8k 1.3× 310 0.2× 616 0.5× 900 1.1× 511 0.7× 331 9.5k
Jorge Salmerón Mexico 46 4.5k 1.6× 222 0.1× 553 0.5× 2.7k 3.3× 621 0.9× 291 10.9k
D M Parkin United Kingdom 30 1.3k 0.4× 149 0.1× 541 0.5× 1.1k 1.3× 264 0.4× 53 6.2k
Thomas R. Viggiano United States 24 2.2k 0.7× 877 0.6× 554 0.5× 897 1.1× 421 0.6× 33 4.2k

Countries citing papers authored by Nick Sheron

Since Specialization
Citations

This map shows the geographic impact of Nick Sheron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Sheron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Sheron more than expected).

Fields of papers citing papers by Nick Sheron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Sheron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Sheron. The network helps show where Nick Sheron may publish in the future.

Co-authorship network of co-authors of Nick Sheron

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Sheron. A scholar is included among the top collaborators of Nick Sheron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Sheron. Nick Sheron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burton, Robyn, Lorenzo Leggio, Alexandre Louvet, Nick Sheron, & Ashwani K. Singal. (2025). Prevention of Alcohol-Associated Liver Disease. The American Journal of Gastroenterology. 120(11). 2487–2501.
2.
3.
Retat, Lise, Peter Jepsen, Alexander M. Martin, et al.. (2023). Preventing liver disease with policy measures to tackle alcohol consumption and obesity: The HEPAHEALTH II study. Journal of Hepatology. 80(4). 543–552. 17 indexed citations
4.
5.
Newsome, Philip N., R Cramb, Suzanne Davison, et al.. (2017). Guidelines on the management of abnormal liver blood tests. Gut. 67(1). 6–19. 340 indexed citations breakdown →
6.
Burton, Robyn, Clive Henn, Don Lavoie, et al.. (2016). A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective. The Lancet. 389(10078). 1558–1580. 226 indexed citations
7.
Sheron, Nick, et al.. (2014). Impact of minimum price per unit of alcohol on patients with liver disease in the UK. Clinical Medicine. 14(4). 396–403. 25 indexed citations
8.
Moodie, Rob, David Stückler, Nick Sheron, et al.. (2013). Profits and Pandemics: Preventing the Harmful Influence of the Tobacco, Alcohol and Ultra Processed Food and Drink Industries.. The Lancet. 381. 2 indexed citations
9.
Sheron, Nick, et al.. (2012). Developing a ‘traffic light’ test with potential for rational early diagnosis of liver fibrosis and cirrhosis in the community. British Journal of General Practice. 62(602). e616–e624. 23 indexed citations
10.
11.
Sheron, Nick, C J Hawkey, & Ian Gilmore. (2011). Projections of alcohol deaths—a wake-up call. The Lancet. 377(9774). 1297–1299. 27 indexed citations
12.
Verrill, Clare, Hannah Markham, Alexa Templeton, Norman J. Carr, & Nick Sheron. (2009). Alcohol‐related cirrhosis—early abstinence is a key factor in prognosis, even in the most severe cases. Addiction. 104(5). 768–774. 92 indexed citations
13.
Silva, Aminda N De, et al.. (2007). Unexpectedly high incidence of indigenous acute hepatitis E within South Hampshire: Time for routine testing?. Journal of Medical Virology. 80(2). 283–288. 29 indexed citations
14.
Sheron, Nick, et al.. (2005). Alcohol related liver problems - strategies for primary care. ePrints Soton (University of Southampton). 1 indexed citations
15.
Verrill, Clare & Nick Sheron. (2005). Alcohol-related harm – a growing crisis: time for action. Clinical Medicine. 5(2). 154–157. 1 indexed citations
16.
Guha, Indra Neil, Brian Stedman, John P. Iredale, & Nick Sheron. (2005). Case report of an arterioportal fistula, presenting with accelerated decompensation and sepsis, twenty-six years after initial liver biopsy. Hepatology Research. 32(4). 252–255. 1 indexed citations
17.
Verrill, Clare, et al.. (2002). Organotypic liver culture in a fluid-air interface using slices of neonatal rat and adult human tissue—a model of fibrosis in vitro. Journal of Pharmacological and Toxicological Methods. 48(2). 103–110. 30 indexed citations
18.
19.
20.
Lau, Johnson Y.N., Nick Sheron, Kayhan T. Nouri‐Aria, Graeme J.M. Alexander, & Roger Williams. (1991). Increased tumor necrosis factor-α receptor number in chronic hepatitis B virus infection. Hepatology. 14(1). 44–50. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Witold Zatoński Breakdown of academic impact, for papers by Susan L. Stewart Breakdown of academic impact, for papers by David Kershenobich Breakdown of academic impact, for papers by Freddy Sitas Breakdown of academic impact, for papers by Meredith S. Shiels Breakdown of academic impact, for papers by Yumei Cao Breakdown of academic impact, for papers by J F Mayberry Breakdown of academic impact, for papers by Jorge Salmerón Breakdown of academic impact, for papers by D M Parkin Breakdown of academic impact, for papers by Thomas R. Viggiano
Rankless by CCL
2026